✦ LIBER ✦

376 Preliminary results from a Phase 1 study of D-3263 HCl, a TRPM8 calcium channel agonist, in patients with advanced cancer

✍ Scribed by A. Tolcher; A. Patnaik; K. Papadopoulos; T. Mays; T. Stephan; D.J. Humble; M.W. Frohlich; R.B. Sims

Book ID: 119603059
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 47 KB
Volume: 8
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(10)72083-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Health-related quality of life in patien

✍ Akira Tsunoda; Naokuni Yasuda; Kentaro Nakao; Kazuhiro Narita; Makoto Watanabe; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 175 KB

45 Preliminary results of a phase 1 stud

45 Preliminary results of a phase 1 study of intravenous administration of GL-ONC1 vaccinia virus including green-fluorescent protein real time imaging in patients with advanced cancer

✍ J. Vitfell-Pedersen; E.M. Karapanagiotou; S. Alam; M. Puglisi; L. Britton; S. Sa 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

8538 POSTER A Phase II Study of Inductio

8538 POSTER A Phase II Study of Induction Chemotherapy With Docetaxel, S-1, and Cisplatin in Patients With Locally Advanced Head & Neck Squamous Cell Cancer (HNSCC) – Preliminary Results

✍ Kyoung, K. Min; Song, S.Y.; Kang, M.K.; Lee, K.H.; Jang, H.W.; Song, H.S.; Kwon, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Efficacy and safety of erlotinib HCl, an

Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: results from a phase II multicenter study

✍ A.N. GORDON; N. FINKLER; R.P. EDWARDS; A.A. GARCIA; M. CROZIER; D.H. IRWIN; E. B 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Vandetanib Versus Gefitinib in Patients

Vandetanib Versus Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study

✍ Natale, R. B.; Bodkin, D.; Govindan, R.; Sleckman, B. G.; Rizvi, N. A.; Capo, A. 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 210 KB

3500 ORAL Preliminary results from a pha

3500 ORAL Preliminary results from a phase II, randomized, double-blind study of sorafenib plus doxorubicin versus placebo plus doxorubicin in patients with advanced hepatocellular carcinoma

✍ G.K. Abou Alfa; P. Johnson; J. Knox; J. Lacava; T. Leung; A. Mori; M.A. Leberre; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB